LAS VEGAS, June 30, 2020 /PRNewswire/ -- JanOne Inc.
(NASDAQ:JAN), a company focused on finding treatments for
conditions that cause severe pain and bringing to market drugs and
therapies with non-addictive pain-relieving properties announced
today that Edgar Ross, MD will join
the company's scientific advisory board. Dr. Ross is the current
Director of the Pain Management Center at Brigham and Women's
Hospital and associate professor of anesthesia at Harvard Medical School. He brings over 40 years of
experience in the medical field and is a highly regarded pain
specialist. Among his many accomplishments, Dr. Ross has published
over 100 manuscripts on pain management, participated in numerous
pain-related clinical trials for some of the world's top pharmaceutical
companies, and served as Chairman of Pfizer's medical and academic
partnership on pain.
Tony Isaac, CEO of JanOne,
commented, "We are honored to have Dr. Ross join our scientific
advisory board. His insight and expertise in pain management and
pain medicine will be invaluable to our mission to bring
non-addictive pain solutions to market."
Dr. Ross has been recognized by the American Pain Society for
top quality clinical care in pain management and has been named as
a top 1% of physicians in the United
States by US News and World Report. Most recently, Dr. Ross
was recognized as one of Boston's
top doctors in 2020 and marks the fifth time he has received the
honor as well as was recently recognized as Castle Connolly's
America's top doctors for the fifth year in a row. In addition to
serving as chairman of Pfizer's partnership on pain, Dr. Ross also
has served as a member of the Blue Cross and Blue Shield Opioid
Prescribing Policy Committee.
Dr. Ross stated, "I look forward to working with JanOne's Chief
Medical Officer Dr. Amol Soin and
Chief Scientific Officer Dr. Tony
Giordano as they are both are recognized for their
accomplishments in pain management and non-addictive pain
medications. I hope my research and clinical experience will
accelerate many new and exciting initiatives currently underway at
JanOne, most notably to find an alternative to prescription opioids
for pain remediation."
Dr. Ross graduated from Wayne State
University School of Medicine in 1980 and is board-certified
for anesthesiology and pain management with clinical interest in
vascular pain.
About JanOne
JanOne is a unique NASDAQ-listed company
that is focused on bringing medications to market to treat diseases
that cause severe pain in an effort to reduce the need for
prescriptions opioids often used to treat disease associated pain.
The company is also exploring solutions for non-addictive pain
medications. The lead candidate is for treating peripheral artery
disease (PAD), a condition that affects over 8.5 million Americans,
with plans currently underway for phase 2b trials. JanOne is currently dedicated to
funding resources toward innovation, technology, and education for
PAD and neuropathic pain. The company continues to operate its
legacy businesses, ARCA Recycling and GeoTraq, under their current
brand names. ARCA Recycling provides turnkey recycling and
replacement services for utilities and other sponsors of energy
efficiency programs. GeoTraq engages in the development, design
and, ultimately, the company expects, sale of Mobile IoT modules.
Please visit www.janone.com for additional information.
Media contact:
Mark Rosenberg
mark@trueparallel.com
919-412-7378
View original content to download
multimedia:http://www.prnewswire.com/news-releases/one-of-the-nations-most-renowned-pain-experts-dr-edgar-ross-joins-janones-scientific-advisory-board-301085884.html
SOURCE JanOne